title: Comparison of Composite International Diagnostic Interview and clinical DSM-III-R criteria checklist diagnoses.
abstract: This article describes a comparison of Composite International Diagnostic Interview (CIDI) diagnostic results and results based on clinicians' observation of CIDI assessments. Psychiatrists scored a DSM-III-R criteria checklist either while observing or after administering 20 CIDI interviews. Overall diagnostic concordance between the checklist and CIDI diagnoses was found to be good (kappa = 0.78). Good diagnostic agreement was also found for 3 groups of DSM-III-R disorders: depressive disorders (kappa = 0.84), psychoactive substance use disorders (kappa = 0.83) and anxiety phobic disorders (kappa = 0.76). These results are consistent with the results from a similar comparison between the CIDI and checklist results for ICD-10 diagnoses.
authors.affiliation: Division of Mental Health, World Health Organization, Geneva, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Janca
authors.forename: L N
authors.initials: LN
authors.lastname: Robins
authors.forename: K K
authors.initials: KK
authors.lastname: Bucholz
authors.forename: T S
authors.initials: TS
authors.lastname: Early
authors.forename: J J
authors.initials: JJ
authors.lastname: Shayka
mesh_terms: D001008:Anxiety Disorders / Q000145:classification / Q000175:diagnosis / Q000523:psychology; D003431:Cross-Cultural Comparison; D003866:Depressive Disorder / Q000145:classification / Q000175:diagnosis / Q000523:psychology; D006801:Humans; D001523:Mental Disorders / Q000145:classification / Q000175:diagnosis* / Q000523:psychology; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data*; D011594:Psychometrics; D011619:Psychotropic Drugs; D019966:Substance-Related Disorders / Q000145:classification / Q000175:diagnosis / Q000523:psychology
chemical_list: D011619:Psychotropic Drugs